Can Trazodone (triazolopyridine antidepressant) cause tremors?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trazodone and Tremors: Clinical Evidence and Management

Yes, trazodone can cause tremors, particularly in overdose situations, but tremors can also occur at therapeutic doses as a reported adverse effect. 1, 2

Mechanism and Evidence

  • Trazodone is a triazolopyridine antidepressant that acts as a serotonin receptor antagonist and reuptake inhibitor (SARI), which can affect neurotransmitter systems involved in movement control 3

  • According to FDA labeling, tremors are specifically listed among the adverse reactions occurring at an incidence of 3-5% in controlled clinical studies with trazodone, compared to 1-4% with placebo 1

  • Tremors are more likely to occur in certain situations:

    • When trazodone is combined with other serotonergic medications (potentially causing serotonin syndrome) 1, 4
    • In overdose situations 5
    • In elderly patients or those with pre-existing neurological conditions 2

Types of Movement Disorders Associated with Trazodone

  • Tremors: The most commonly reported movement-related side effect 1

  • Parkinsonism: Case reports document trazodone-induced parkinsonism, particularly in older adults, presenting with:

    • Cogwheel rigidity
    • Shuffling gait
    • Coarse tremors of extremities 2
  • Myoclonus: Reported particularly when trazodone is combined with other serotonergic medications like fluoxetine 4

  • Other neurological effects: The FDA label also mentions incoordination (5% incidence), muscle twitches, and numbness/paresthesia as potential adverse effects 1

Risk Factors for Trazodone-Induced Tremors

  • Age: Elderly patients appear more susceptible to neurological side effects 2

  • Polypharmacy: Concomitant use of medications that:

    • Inhibit CYP3A4 (may increase trazodone levels) 1
    • Have serotonergic properties (may cause serotonin syndrome) 1, 4
    • Affect dopaminergic pathways 2
  • Dosage: Higher doses increase risk of adverse effects, including tremors 1, 3

Clinical Implications and Management

  • Monitoring: Patients starting trazodone should be monitored for the emergence of tremors or other movement disorders 1

  • Dose adjustment: Consider dose reduction if tremors develop at therapeutic doses 1

  • Discontinuation: In cases of severe tremors or development of parkinsonism symptoms, discontinuation of trazodone may be necessary 2

  • Resolution timeline: Tremors and movement disorders typically resolve within days to a week after discontinuation 2

  • Alternative medications: For patients requiring antidepressant therapy who develop tremors on trazodone, consider switching to agents with lower reported incidence of movement disorders 5

Special Considerations

  • Cardiac patients: Trazodone has been implicated in cardiac arrhythmias including torsade de pointes, especially in overdose situations, which may complicate management of patients with tremors who also have cardiac issues 5, 1

  • Drug interactions: Be particularly cautious when combining trazodone with other medications that might affect serotonergic systems or inhibit trazodone metabolism 1, 4

  • Elderly patients: Lower starting doses and more careful monitoring are recommended due to increased susceptibility to adverse effects including tremors 2

In conclusion, while trazodone is generally considered to have a favorable side effect profile compared to many other antidepressants, tremors remain a recognized adverse effect that clinicians should monitor for, particularly in vulnerable populations or when using higher doses.

References

Research

Trazodone-induced parkinsonism: A case report.

International journal of clinical pharmacology and therapeutics, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.